gene	transcript	isCanonical	event	eventIsHighDriver	germline	reported	studyNctId	studyTitle	studyAcronym	studyGender	countriesOfStudy	matchGender	treatment	sourceRelevantTreatmentApproach	relevantTreatmentApproach	onLabel	level	direction	sources
BRAF	123	true	p.Val600Glu	true	false	true							Cetuximab + Encorafenib	BRAF Inhibitor		false	A	RESPONSIVE	CKB_EVIDENCE|BRAF V600E|https://ckbhome.jax.org|HOTSPOT_MUTATION||https://www.nccn.org/professionals/physician_gls/default.aspx;
			HR deficiency		false	false	NCT1	study1	study1	both	Netherlands		Talazoparib			false	B	RESPONSIVE	CKB_TRIAL|HRD pos|https://ckbhome.jax.org|SIGNATURE||https://clinicaltrials.gov/study/
			HR deficiency		false	true	NCT2	study2		both	Belgium,Netherlands		Encorafenib			true	B	RESPONSIVE	CKB_TRIAL|HRD pos|https://ckbhome.jax.org/|SIGNATURE||https://clinicaltrials.gov/study/